O'neill Gilmore Neil Insider Trades

Insider Trading History

Track insider trading activity for O'neill Gilmore Neil. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $2.8M 1,015,200 shares
Last Trade
Mar 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.58M 1,015,200 shares
$2.54
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $728k 263,693 shares
Last Trade
Mar 03, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.9k 5,394 shares
$2.02
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $743k 269,087 shares
Last Trade
Dec 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$12k 5,603 shares
$2.15
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $758k 274,690 shares
Last Trade
Sep 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.5k 5,592 shares
$2.60
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $774k 280,282 shares
Last Trade
Jun 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$26.1k 15,192 shares
$1.72
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $2.29M 828,000 shares
Last Trade
Mar 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.73M 1,003,000 shares
$1.72
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $816k 295,474 shares
Last Trade
Mar 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$28.4k 16,632 shares
$1.71
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $861k 312,106 shares
Last Trade
Dec 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.37k 1,618 shares
$2.08
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $866k 313,724 shares
Last Trade
Sep 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.32k 1,555 shares
$3.42
$2.76
Unity Biotechnology
Unity Biotechnology UBX
Director
Holding Value $2k 10,000 shares
Last Trade
Jun 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.8k 10,000 shares
$1.38
$0.20
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $870k 315,279 shares
Last Trade
Jun 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.1k 12,191 shares
$5.50
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $904k 327,470 shares
Last Trade
Mar 05, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$733k 77,824 shares
$9.42
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $1.12M 405,294 shares
Last Trade
Mar 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.13M 392,100 shares
$10.53
$2.76
Unity Biotechnology
Unity Biotechnology UBX
Director
Holding Value $1.2k 6,000 shares
Last Trade
Jun 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.5k 6,000 shares
$3.25
$0.20
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $359k 130,169 shares
Last Trade
Jun 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$61.6k 6,486 shares
$9.50
$2.76
Editas Medicine
Editas Medicine EDIT
CEO
Holding Value $414k 150,000 shares
Last Trade
Mar 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 150,000 shares
$8.72
$2.76
Unity Biotechnology
Unity Biotechnology UBX
Director
Holding Value $5k 25,000 shares
Last Trade
Jun 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$149k 25,000 shares
$5.94
$0.20
Editas Medicine
Editas Medicine EDIT
Director, CEO
Holding Value $2.62M 950,209 shares
Last Trade
Jun 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11M 950,209 shares
$11.54
$2.76
Aptinyx
Aptinyx APTX
Director
Holding Value $3.84k 40,000 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20k 40,000 shares
$0.50
$0.10
Aptinyx
Aptinyx APTX
Director
Holding Value $7.68k 80,000 shares
Last Trade
Oct 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 80,000 shares
$2.26
$0.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up